Regardless, NEAT1 downregulation has been reported in invasive breast carcinoma, oesophageal cancer, pheochromocytoma, and paraganglioma, suggesting NEAT1 plays a tumour-suppressor role in these malignancies [6]. Here, NEAT1 is linked to invasive breast carcinoma.